Department of Health Policy and Management
We train and inspire the next generation of health care leaders to improve health care delivery systems and mitigate public health risks around the world.
677 Huntington Avenue, Kresge Building
Boston, MA 02115
News
-
Course highlights the health impacts of homelessness
Harvard Chan School’s two-year-old course on homelessness and health is one of many pieces of the School’s new pilot Initiative on Health and Homelessness (IHH), an effort aimed at advancing education, research, and practice regarding housing instability’s devastating impacts on health.
-
Jesse Bump, Nancy Turnbull receive inaugural Sastry Awards for outstanding teaching
Jesse Bump and Nancy Turnbull are the 2022 recipients of a new award recognizing outstanding teaching in public health at Harvard T.H. Chan School of Public Health.
-
Student’s journey to U.S. to save daughter sparks a career in public health
In a recent interview, Oana Geambasu described how she unintentionally became an adviser to Romania’s health minister, and what it means to her to be the country’s first graduate from the School in almost 100 years.
-
Tackling disparities and stigma around obesity and mental health care for minority populations
Physician and mother of four Tiffani Bell Washington, MPH ’22, was honored by the National Minority Quality Forum as one of its “40 Under 40.”
-
Shock to the system
Ellen Chappelka, MPH ’22, was taken aback by preventable health problems she saw while working as an EMT in New Orleans. Now she wants to change systemic issues that make people vulnerable in the first place.
-
With free health clinic, student brings health care to Rhode Island’s underserved
Akosua Dankwah, DrPH ’22, is applying what she’s learned to help the WTL Health Clinic expand its mission.
-
Program to help business leaders address public health challenges
A new certificate program for business leaders will focus on why incorporating public health considerations as a key part of their work can help people, communities, and the planet—and help businesses thrive at the same time.
-
Political affiliation may have swayed prescribing of ineffective COVID drugs
Two treatments that have been shown to be ineffective against COVID-19—hydroxychloroquine and ivermectin—were more heavily prescribed in U.S. counties with a higher Republican vote share in the 2020 presidential election, according to a new study.
-
What led to the opioid crisis—and how to fix it
Howard Koh, professor of the practice of public health leadership, discusses factors contributing to the opioid crisis and recommendations on how to curb it.
-
Those at highest risk for severe COVID-19 often least likely to get monoclonal antibodies
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard Chan School.
